Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0450
-0.0020 (-4.26%)
Mar 26, 2026, 4:00 PM EST

Galera Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6.388.2918.264.2719.86
Short-Term Investments
---27.3351.36
Cash & Short-Term Investments
6.388.2918.2631.671.22
Cash Growth
-23.09%-54.60%-42.22%-55.63%-2.14%
Other Receivables
-0.64-3.24-
Receivables
-0.64-3.24-
Prepaid Expenses
0.721.083.373.656.18
Restricted Cash
---0.05-
Total Current Assets
7.11021.6338.5477.39
Property, Plant & Equipment
--1.280.480.82
Goodwill
--0.880.880.88
Other Intangible Assets
--2.262.262.26
Other Long-Term Assets
0.10.10.091.881.96
Total Assets
7.210.126.1444.0483.31
Accounts Payable
0.271.281.383.585.04
Accrued Expenses
0.380.393.459.757.63
Current Portion of Leases
--0.130.040.26
Total Current Liabilities
0.651.674.9613.3812.94
Long-Term Debt
-151.05151.05139.64128.06
Long-Term Leases
--1.12-0.04
Long-Term Deferred Tax Liabilities
--0.20.20.27
Other Long-Term Liabilities
-1.06---
Total Liabilities
0.65153.77157.33153.22141.32
Common Stock
0.080.080.050.030.03
Additional Paid-In Capital
311.21308.25306.17269.14258.09
Retained Earnings
-307.31-456.36-437.41-378.32-316.1
Comprehensive Income & Other
----0.02-0.01
Total Common Equity
3.97-148.04-131.19-109.18-58
Shareholders' Equity
6.55-143.67-131.19-109.18-58
Total Liabilities & Equity
7.210.126.1444.0483.31
Total Debt
-151.05152.3139.68128.37
Net Cash (Debt)
6.38-142.76-134.04-108.08-57.15
Net Cash Per Share
0.06-2.61-3.01-3.99-2.22
Filing Date Shares Outstanding
75.4675.4654.3942.8326.8
Total Common Shares Outstanding
75.4675.4654.3928.5126.46
Working Capital
6.458.3416.6725.1664.46
Book Value Per Share
0.05-1.96-2.41-3.83-2.19
Tangible Book Value
3.97-148.04-134.32-112.32-61.14
Tangible Book Value Per Share
0.05-1.96-2.47-3.94-2.31
Machinery
--0.481.871.85
Leasehold Improvements
--0.050.270.26
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.